Comparison of Two Different Alveolar Ridge Preservation Techniques

NCT ID: NCT02482987

Last Updated: 2017-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare two barrier membrane products, Cytoplast (dPTFE) and BioXclude (human amnion chorion allograft), for their relative efficacies in dental socket preservation procedures, both when the socket is filled and overfilled with freeze dried bone allograft (FDBA).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This single-blind, randomized clinical trial aims to compare two different, commercially available materials to assess their relative efficacies in socket preservation procedures after tooth extraction. Patients presenting with single teeth deemed clinically hopeless and treatment planned for removal in the normal course of clinical dentistry will be considered for this study. If eligible, a ridge/socket preservation procedure will be performed at the time of extraction. Periodontics residents will perform the procedure under the supervision of board certified staff. Patients will be randomized via concealed random number sequence into one of four groups, based on a combination of materials and graft placement techniques. Patients will be equally distributed into the following groups: (1) dense polytetrafluoroethylene (Cytoplast) (2) Cytoplast with additional buccal augmentation/onlay graft, (3) human amniotic-tissue derived membrane (BioXclude), and (4) BioXclude with additional buccal augmentation/onlay graft. All four treatment groups are consistent with the current standard of care, and this study seeks to compare techniques and materials as part of routine, clinical/periodontal therapy in order to determine superiority. Approximately 150 patients will be enrolled and distributed equally among the four groups. Any post-operative complications will be managed and documented during follow-up appointments at 1, 2 and 4 weeks. Cone beam computed tomography (CBCT) will be used as the primary assessment tool, and scans will be compared between a pre-operative baseline time point and a scan taken after 4 months of healing to prepare for implant placement. The primary dependent variables will be (1) percent of baseline alveolar ridge changes (both horizontal and vertical) and (2) whether or not the anticipated dental implant could be placed appropriately. Secondary outcomes include ease of use, perceptions of pain, complications, cost-effectiveness, and changes in keratinized tissue.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Loss of Teeth Due to Extraction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cytoplast

Patients will receive ridge preservation procedure with a Cytoplast barrier membrane

Group Type EXPERIMENTAL

dense polytetrafluoroethylene (dPTFE) membrane Cytoplast

Intervention Type DEVICE

ridge preservation intervention using the dPTFE membrane device

Ridge Preservation with overlay graft

Intervention Type PROCEDURE

ridge preservation intervention with additional freeze dried bone allograft (FDBA) placed buccal to the socket

Ridge Preservation without overlay graft

Intervention Type PROCEDURE

ridge preservation without overlay graft / traditional FDBA placement into the socket only

BioXclude

Patients will receive ridge preservation procedure with a BioXclude barrier membrane

Group Type EXPERIMENTAL

human amniotic-tissue derived membrane BioXclude

Intervention Type DEVICE

ridge preservation intervention using the dPTFE membrane device

Ridge Preservation with overlay graft

Intervention Type PROCEDURE

ridge preservation intervention with additional freeze dried bone allograft (FDBA) placed buccal to the socket

Ridge Preservation without overlay graft

Intervention Type PROCEDURE

ridge preservation without overlay graft / traditional FDBA placement into the socket only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dense polytetrafluoroethylene (dPTFE) membrane Cytoplast

ridge preservation intervention using the dPTFE membrane device

Intervention Type DEVICE

human amniotic-tissue derived membrane BioXclude

ridge preservation intervention using the dPTFE membrane device

Intervention Type DEVICE

Ridge Preservation with overlay graft

ridge preservation intervention with additional freeze dried bone allograft (FDBA) placed buccal to the socket

Intervention Type PROCEDURE

Ridge Preservation without overlay graft

ridge preservation without overlay graft / traditional FDBA placement into the socket only

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cytoplast BioXclude

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All active duty military patients (age 18-65) referred to the investigators' facility's periodontics department for diagnosis of "hopeless" tooth with documented confirmation of diagnosis by periodontal staff
* Eligible for extraction and ridge preservation (adequately healthy and not otherwise disqualified)

Exclusion Criteria

* Pregnant or breastfeeding
* History of allergy to involved products
* Current acute infection at the site (chronic periapical infections will not exclude the patient)
* Elian Type 3 extraction sockets
* Sites not treatment planned for implant therapy
* Third molar sites
* American Society of Anesthesiology Category III patients (medically compromised)
* Active duty military patients in a student status
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eisenhower Army Medical Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Brandon Coleman

Assistant Director, Advanced Education Program in Periodontics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brandon Coleman, DDS,MS

Role: PRINCIPAL_INVESTIGATOR

US Army Fort Gordon DENTAC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tingay Dental Clinic

Fort Gordon, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

408953-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.